Due to the high difference in range of sensitivity to Chk1 inhibitor, we compared the baseline gene expression profiles of the cell lines most sensitive to Chk1 inhibitor with the most resistant ones among the entire panel of B-cell lymphoma cell lines. Here, CHEK1 is linked to B-cell non-Hodgkin lymphoma.